David P. Wright

David Wright was a distinguished figure in the realm of biopharmaceuticals, renowned for his visionary leadership and unwavering commitment to innovation. David’s journey in the biopharmaceutical arena began with a series of pivotal roles at renowned companies. As President and Chief Executive Officer of PharmAthene, Inc. from 2003 to 2010, he led the charge in pioneering groundbreaking biodefense and biopharmaceutical initiatives. His strategic acumen and keen market insights propelled PharmAthene to the forefront of innovation, solidifying its position as a trailblazer in the field.

Prior to his tenure at PharmAthene, David held key positions at GenVec Inc., where his instrumental role in integrating critical functions such as business development, drug development, manufacturing, sales, and marketing underscored his adeptness in driving organizational synergy and achieving strategic objectives.

Before joining GenVec, David Wright distinguished himself as President and Chief Business Officer of Guilford Pharmaceuticals, Inc., where he played a pivotal role in shaping the company’s growth trajectory. His tenure at MedImmune, Inc. from 1990 to 2000 was equally impactful, as he spearheaded the development of robust sales and marketing operations, played a key role in the company’s IPO, and contributed significantly to MedImmune’s commercial success.